Trade Orthofix - OFIX CFD

Trading Conditions

• Spread: 0.07
• Long position overnight feeLong position overnight feeMargin. Your investment$1,000.00Overnight feeCharges from full value of position-0.026179 %(-$1.05)Trade size with leverage ~ $5,000.00Short position overnight fee ~ $4,000.00Go to platform: -0.026179%
• Short position overnight feeShort position overnight feeMargin. Your investment$1,000.00Overnight feeCharges from full value of position0.003957 %($0.16)Trade size with leverage ~ $5,000.00Short position overnight fee ~ $4,000.00Go to platform: 0.003957%
• Overnight fee time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 20
• Stock exchange: United States of America
• Commission on trade: 0%

• Margin. Your investment: $1,000.00
• Overnight feeCharges from full value of position: -0.026179 %
  (-$1.05)

• Margin. Your investment: $1,000.00
• Overnight feeCharges from full value of position: 0.003957 %
  ($0.16)

Key Stats

• Prev. Close: 13.19
• Open: 13.54
• 1-Year Change: -27.09%
• Day's Range: 13.5 - 13.75

Orthofix Company profile

About Orthofix Medical Inc

Orthofix Medical Inc. is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The Company has two reporting segments: Global Spine and Global Orthopedics. The Global spine segment provide three product categories such as Bone Growth Therapies, Spinal Implants, and Biologics. Its products also consist of bone growth therapies devices, motion preservation products, spine fixation products, and orthopedics products. The Global Orthopedics offers products and solutions that allow physicians to treat a variety of orthopedic conditions in adults and children unrelated to the spine. It distribute its products globally to hospitals and health providers.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Orthofix Medical Inc revenues increased 14% to $464.5M. Net loss totaled $38.4M vs. income of $2.5M. Revenues reflect Global Spine segment increase of 12% to $359M, United States segment increase of 11% to $361.9M, United Kingdom segment increase of 48% to $10.6M. Net loss reflects Sales and marketing - Balancing value increase of 9% to $217.9M (expense), Other income (expense).

Equity composition

Common Stock $.10 Par, 07/10, 50M auth., 17,641,438 issd. Insiders own 1.39%. IPO 4/92, 3M shares @ $12 by Alex.Brown.